Uracil/tegafur as a possible salvage therapy in chemo-refractory colorectal cancer patients: a single institutional retrospective study

Bayoglu, Ibrahim; Yildiz, İBRAHİM; Varol, Umut; Cokmert, Suna; Alacacioglu, Ahmet; Kucukzeybek, Yuksel; Akyol, Murat; Demir, Lutfiye; Dirican, Ahmet; Tarhan, Oktay

doi:10.5114/wo.2015.53374

Uracil/tegafur as a possible salvage therapy in chemo-refractory colorectal cancer patients: a single institutional retrospective study

Copy For Citation

Bayoglu I. V., Yildiz İ., Varol U., Cokmert S., Alacacioglu A., Kucukzeybek Y., ...More

WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, vol.19, no.5, pp.385-390, 2015 (ESCI)

Publication Type: Article / Article
Volume: 19 Issue: 5
Publication Date: 2015
Doi Number: 10.5114/wo.2015.53374
Journal Name: WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY
Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus
Page Numbers: pp.385-390
Keywords: uracil/tegafur, metastatic colorectal cancer, heavily pretreated, salvage therapy
Acibadem Mehmet Ali Aydinlar University Affiliated: No

Abstract

Aim of the study: Our aim was to determine the activity and toxicity of uracil/tegafur and leucovorin combination in metastatic colorectal cancer (mCRC) patients who have progressed with all currently active agents.